HEADER HYDROLASE 04-FEB-21 7NEU TITLE INHIBITOR COMPLEX WITH THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR TITLE 2 (TAFIA) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBOXYPEPTIDASE B2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CARBOXYPEPTIDASE U,CPU,PLASMA CARBOXYPEPTIDASE B,PCPB, COMPND 5 THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR,TAFI; COMPND 6 EC: 3.4.17.20; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CPB2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS INHIBITOR, COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.G.BROWN,A.P.SCHAFFNER,L.M.VUILLARD,P.GLOANEC,E.RAIMBAULD REVDAT 2 21-APR-21 7NEU 1 JRNL REVDAT 1 07-APR-21 7NEU 0 JRNL AUTH A.P.SCHAFFNER,P.SANSILVESTRI-MOREL,N.DESPAUX,E.RUANO, JRNL AUTH 2 T.PERSIGAND,A.RUPIN,P.MENNECIER,M.O.VALLEZ,E.RAIMBAUD, JRNL AUTH 3 P.DESOS,P.GLOANEC JRNL TITL PHOSPHINANES AND AZAPHOSPHINANES AS POTENT AND SELECTIVE JRNL TITL 2 INHIBITORS OF ACTIVATED THROMBIN-ACTIVATABLE FIBRINOLYSIS JRNL TITL 3 INHIBITOR (TAFIA). JRNL REF J.MED.CHEM. V. 64 3897 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 33764059 JRNL DOI 10.1021/ACS.JMEDCHEM.0C02072 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 12702 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.897 REMARK 3 FREE R VALUE TEST SET COUNT : 622 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 873 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.25 REMARK 3 BIN R VALUE (WORKING SET) : 0.3290 REMARK 3 BIN FREE R VALUE SET COUNT : 50 REMARK 3 BIN FREE R VALUE : 0.3830 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3187 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 29 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.58900 REMARK 3 B22 (A**2) : 2.40200 REMARK 3 B33 (A**2) : -0.81200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.419 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.352 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 38.840 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.923 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.821 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3345 ; 0.010 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3029 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4556 ; 1.769 ; 1.651 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6958 ; 1.251 ; 1.583 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 398 ; 7.981 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 173 ;30.072 ;22.139 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 519 ;18.696 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;21.467 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 441 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3776 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 813 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 674 ; 0.213 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 22 ; 0.144 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1589 ; 0.177 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 84 ; 0.188 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 3 ; 0.143 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): 1 ; 0.452 ; 0.200 REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1592 ; 0.558 ; 1.436 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1591 ; 0.558 ; 1.437 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1987 ; 1.001 ; 2.152 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1988 ; 1.001 ; 2.152 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1753 ; 0.475 ; 1.486 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1754 ; 0.475 ; 1.487 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2568 ; 0.872 ; 2.213 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2569 ; 0.872 ; 2.214 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 401 REMARK 3 RESIDUE RANGE : A 501 A 501 REMARK 3 RESIDUE RANGE : A 502 A 502 REMARK 3 ORIGIN FOR THE GROUP (A): -27.3585 -20.5237 8.1501 REMARK 3 T TENSOR REMARK 3 T11: 0.2166 T22: 0.0059 REMARK 3 T33: 0.1805 T12: 0.0082 REMARK 3 T13: -0.0191 T23: -0.0119 REMARK 3 L TENSOR REMARK 3 L11: 0.8795 L22: 1.0365 REMARK 3 L33: 1.9879 L12: 0.1469 REMARK 3 L13: -0.5579 L23: -0.2846 REMARK 3 S TENSOR REMARK 3 S11: 0.0109 S12: 0.0190 S13: -0.0238 REMARK 3 S21: 0.0317 S22: 0.0035 S23: 0.0113 REMARK 3 S31: -0.0319 S32: -0.0961 S33: -0.0145 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7NEU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1292113825. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12711 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 42.060 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.12900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.4800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.87 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.49100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.320 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM MES, 300MM AMMONIUM CHLORIDE, REMARK 280 35% PEG 3350, PH 6.25, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.04000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 32.04000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 49.71000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 78.67500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 49.71000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 78.67500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 32.04000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 49.71000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 78.67500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 32.04000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 49.71000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 78.67500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 144 REMARK 465 GLU A 145 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 12 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 42 CG CD CE NZ REMARK 470 LYS A 44 CG CD CE NZ REMARK 470 GLU A 116 CG CD OE1 OE2 REMARK 470 GLN A 146 CG CD OE1 NE2 REMARK 470 THR A 147 OG1 CG2 REMARK 470 LYS A 268 CG CD CE NZ REMARK 470 LYS A 306 CG CD CE NZ REMARK 470 LYS A 327 CG CD CE NZ REMARK 470 VAL A 401 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD1 HIS A 159 ZN ZN A 502 1.01 REMARK 500 HD1 HIS A 288 ZN ZN A 502 1.13 REMARK 500 O HIS A 396 HD22 ASN A 400 1.58 REMARK 500 ND2 ASN A 86 OE2 GLU A 376 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 43 -1.73 79.42 REMARK 500 ASP A 75 49.21 -105.12 REMARK 500 ASP A 87 -68.42 -7.13 REMARK 500 LYS A 133 31.82 92.79 REMARK 500 THR A 147 -140.65 -83.83 REMARK 500 LYS A 149 172.71 165.50 REMARK 500 ASN A 150 133.85 -36.68 REMARK 500 ILE A 182 -64.12 -124.19 REMARK 500 LYS A 212 -42.56 -132.97 REMARK 500 ASN A 213 89.20 -151.40 REMARK 500 ALA A 224 -69.07 12.57 REMARK 500 GLU A 244 -141.62 -96.80 REMARK 500 TYR A 260 151.33 175.89 REMARK 500 SER A 291 -9.46 152.90 REMARK 500 GLN A 292 61.45 62.54 REMARK 500 ARG A 320 -49.00 -28.47 REMARK 500 LEU A 340 -3.00 99.76 REMARK 500 ALA A 343 76.93 -155.84 REMARK 500 ASP A 366 -142.78 -110.03 REMARK 500 ILE A 393 -73.15 -50.06 REMARK 500 ASN A 400 -45.50 -150.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 502 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 159 ND1 REMARK 620 2 GLU A 162 OE1 108.5 REMARK 620 3 GLU A 162 OE2 80.6 54.3 REMARK 620 4 HIS A 288 ND1 107.4 93.2 146.8 REMARK 620 5 U9K A 501 O2 125.0 119.9 106.8 94.8 REMARK 620 N 1 2 3 4 DBREF 7NEU A 2 401 UNP Q96IY4 CBPB2_HUMAN 24 423 SEQADV 7NEU THR A 147 UNP Q96IY4 ALA 169 CONFLICT SEQADV 7NEU CYS A 305 UNP Q96IY4 SER 327 CONFLICT SEQADV 7NEU ILE A 329 UNP Q96IY4 THR 351 CONFLICT SEQADV 7NEU TYR A 333 UNP Q96IY4 HIS 355 CONFLICT SEQADV 7NEU GLN A 335 UNP Q96IY4 HIS 357 CONFLICT SEQRES 1 A 400 GLN SER GLY GLN VAL LEU ALA ALA LEU PRO ARG THR SER SEQRES 2 A 400 ARG GLN VAL GLN VAL LEU GLN ASN LEU THR THR THR TYR SEQRES 3 A 400 GLU ILE VAL LEU TRP GLN PRO VAL THR ALA ASP LEU ILE SEQRES 4 A 400 VAL LYS LYS LYS GLN VAL HIS PHE PHE VAL ASN ALA SER SEQRES 5 A 400 ASP VAL ASP ASN VAL LYS ALA HIS LEU ASN VAL SER GLY SEQRES 6 A 400 ILE PRO CYS SER VAL LEU LEU ALA ASP VAL GLU ASP LEU SEQRES 7 A 400 ILE GLN GLN GLN ILE SER ASN ASP THR VAL SER PRO ARG SEQRES 8 A 400 ALA SER ALA SER TYR TYR GLU GLN TYR HIS SER LEU ASN SEQRES 9 A 400 GLU ILE TYR SER TRP ILE GLU PHE ILE THR GLU ARG HIS SEQRES 10 A 400 PRO ASP MET LEU THR LYS ILE HIS ILE GLY SER SER PHE SEQRES 11 A 400 GLU LYS TYR PRO LEU TYR VAL LEU LYS VAL SER GLY LYS SEQRES 12 A 400 GLU GLN THR ALA LYS ASN ALA ILE TRP ILE ASP CYS GLY SEQRES 13 A 400 ILE HIS ALA ARG GLU TRP ILE SER PRO ALA PHE CYS LEU SEQRES 14 A 400 TRP PHE ILE GLY HIS ILE THR GLN PHE TYR GLY ILE ILE SEQRES 15 A 400 GLY GLN TYR THR ASN LEU LEU ARG LEU VAL ASP PHE TYR SEQRES 16 A 400 VAL MET PRO VAL VAL ASN VAL ASP GLY TYR ASP TYR SER SEQRES 17 A 400 TRP LYS LYS ASN ARG MET TRP ARG LYS ASN ARG SER PHE SEQRES 18 A 400 TYR ALA ASN ASN HIS CYS ILE GLY THR ASP LEU ASN ARG SEQRES 19 A 400 ASN PHE ALA SER LYS HIS TRP CYS GLU GLU GLY ALA SER SEQRES 20 A 400 SER SER SER CYS SER GLU THR TYR CYS GLY LEU TYR PRO SEQRES 21 A 400 GLU SER GLU PRO GLU VAL LYS ALA VAL ALA SER PHE LEU SEQRES 22 A 400 ARG ARG ASN ILE ASN GLN ILE LYS ALA TYR ILE SER MET SEQRES 23 A 400 HIS SER TYR SER GLN HIS ILE VAL PHE PRO TYR SER TYR SEQRES 24 A 400 THR ARG SER LYS CYS LYS ASP HIS GLU GLU LEU SER LEU SEQRES 25 A 400 VAL ALA SER GLU ALA VAL ARG ALA ILE GLU LYS ILE SER SEQRES 26 A 400 LYS ASN ILE ARG TYR THR TYR GLY GLN GLY SER GLU THR SEQRES 27 A 400 LEU TYR LEU ALA PRO GLY GLY GLY ASP ASP TRP ILE TYR SEQRES 28 A 400 ASP LEU GLY ILE LYS TYR SER PHE THR ILE GLU LEU ARG SEQRES 29 A 400 ASP THR GLY THR TYR GLY PHE LEU LEU PRO GLU ARG TYR SEQRES 30 A 400 ILE LYS PRO THR CYS ARG GLU ALA PHE ALA ALA VAL SER SEQRES 31 A 400 LYS ILE ALA TRP HIS VAL ILE ARG ASN VAL HET U9K A 501 58 HET ZN A 502 1 HET NA A 503 1 HET CL A 504 1 HET EDO A 505 10 HET NAG A 506 28 HET NAG A 507 28 HETNAM U9K (1R,3S)-3-(4-AMMONIOBUTYL)-1-(4-FLUORO-2-(1-METHYL-1H- HETNAM 2 U9K IMIDAZOL-5-YL)BENZYL)-1,4-AZAPHOSPHINAN-1-IUM-3- HETNAM 3 U9K CARBOXYLATE 4,4-DIOXIDE HETNAM ZN ZINC ION HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN U9K 4-[(1~{R},3~{S})-3-CARBOXY-1-[[4-FLUORANYL-2-(3- HETSYN 2 U9K METHYLIMIDAZOL-4-YL)PHENYL]METHYL]-4-OXIDANYL-4- HETSYN 3 U9K OXIDANYLIDENE-1,4$L^{5}-AZAPHOSPHINAN-1-IUM-3- HETSYN 4 U9K YL]BUTYLAZANIUM HETSYN EDO ETHYLENE GLYCOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 U9K C20 H30 F N4 O4 P 2+ FORMUL 3 ZN ZN 2+ FORMUL 4 NA NA 1+ FORMUL 5 CL CL 1- FORMUL 6 EDO C2 H6 O2 FORMUL 7 NAG 2(C8 H15 N O6) FORMUL 9 HOH *29(H2 O) HELIX 1 AA1 THR A 13 TYR A 27 1 15 HELIX 2 AA2 THR A 36 ILE A 40 5 5 HELIX 3 AA3 ASP A 54 SER A 65 1 12 HELIX 4 AA4 ASP A 75 SER A 85 1 11 HELIX 5 AA5 ALA A 95 GLN A 100 5 6 HELIX 6 AA6 SER A 103 HIS A 118 1 16 HELIX 7 AA7 TRP A 163 TYR A 180 1 18 HELIX 8 AA8 ILE A 183 THR A 187 5 5 HELIX 9 AA9 ASN A 188 LEU A 192 5 5 HELIX 10 AB1 ASN A 202 LYS A 212 1 11 HELIX 11 AB2 ASP A 232 ASN A 236 5 5 HELIX 12 AB3 GLU A 264 ASN A 277 1 14 HELIX 13 AB4 ASP A 307 SER A 326 1 20 HELIX 14 AB5 GLY A 346 LEU A 354 1 9 HELIX 15 AB6 TYR A 370 LEU A 374 5 5 HELIX 16 AB7 PRO A 375 ARG A 377 5 3 HELIX 17 AB8 TYR A 378 ARG A 399 1 22 SHEET 1 AA1 4 ILE A 29 GLN A 33 0 SHEET 2 AA1 4 VAL A 46 ASN A 51 -1 O PHE A 49 N VAL A 30 SHEET 3 AA1 4 GLY A 4 ALA A 9 -1 N ALA A 9 O VAL A 46 SHEET 4 AA1 4 CYS A 69 LEU A 73 -1 O LEU A 73 N VAL A 6 SHEET 1 AA2 8 LEU A 122 SER A 129 0 SHEET 2 AA2 8 PRO A 135 VAL A 141 -1 O VAL A 138 N ILE A 125 SHEET 3 AA2 8 ASP A 194 MET A 198 -1 O VAL A 197 N LEU A 139 SHEET 4 AA2 8 ALA A 151 ASP A 155 1 N ILE A 154 O MET A 198 SHEET 5 AA2 8 ILE A 281 HIS A 288 1 O MET A 287 N ASP A 155 SHEET 6 AA2 8 TYR A 358 GLU A 363 1 O ILE A 362 N HIS A 288 SHEET 7 AA2 8 HIS A 293 PHE A 296 -1 N VAL A 295 O THR A 361 SHEET 8 AA2 8 THR A 332 GLN A 335 1 O GLY A 334 N ILE A 294 SSBOND 1 CYS A 156 CYS A 169 1555 1555 2.06 SSBOND 2 CYS A 228 CYS A 252 1555 1555 2.03 SSBOND 3 CYS A 243 CYS A 257 1555 1555 2.05 LINK ND2 ASN A 22 C1 NAG A 506 1555 1555 1.46 LINK ND2 ASN A 51 C1 NAG A 507 1555 1555 1.47 LINK OD2 ASP A 75 NA NA A 503 1555 6445 1.96 LINK ND1 HIS A 159 ZN ZN A 502 1555 1555 1.85 LINK OE1 GLU A 162 ZN ZN A 502 1555 1555 2.13 LINK OE2 GLU A 162 ZN ZN A 502 1555 1555 2.54 LINK ND1 HIS A 288 ZN ZN A 502 1555 1555 1.93 LINK O2 U9K A 501 ZN ZN A 502 1555 1555 1.99 CISPEP 1 GLN A 33 PRO A 34 0 -9.41 CISPEP 2 SER A 289 TYR A 290 0 2.30 CISPEP 3 PRO A 297 TYR A 298 0 12.75 CISPEP 4 ARG A 365 ASP A 366 0 -1.48 CRYST1 99.420 157.350 64.080 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010058 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006355 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015605 0.00000